Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

被引:662
作者
Lee, Chun Geun [1 ]
Da Silva, Carla A. [1 ]
Dela Cruz, Charles S. [1 ]
Ahangari, Farida [1 ]
Ma, Bing [1 ]
Kang, Min-Jong [1 ]
He, Chuan-Hua [1 ]
Takyar, Seyedtaghi [1 ]
Elias, Jack A. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm & Crit Care Med, New Haven, CT 06520 USA
来源
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 | 2011年 / 73卷
关键词
asthma; fibrosis; BRP-39/YKL-40; AMCase; chitotriosidase; ACIDIC MAMMALIAN CHITINASE; HUMAN CARTILAGE GLYCOPROTEIN-39; NECROSIS-FACTOR-ALPHA; CHITOTRIOSIDASE GENE-EXPRESSION; SERUM YKL-40 LEVEL; PARASITE CHITINASE; SECRETED GLYCOPROTEIN; MACROPHAGE ACTIVATION; RHEUMATOID-ARTHRITIS; INTERFERON-GAMMA;
D O I
10.1146/annurev-physiol-012110-142250
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The 18 glycosyl hydrolase family of chitinases is an ancient gene family that is widely expressed from prokaryotes to eukaryotes. In mammals, despite the absence of endogenous chitin, a number of chitinases and chitinase-like proteins (C/CLPs) have been identified. However, their roles have only recently begun to be elucidated. Acidic mammalian chitinase (AMCase) inhibits chitin-induced innate inflammation; augments chitin-free, allergen-induced Th2 inflammation; and mediates effector functions of IL-13. The CLPs BRP-39/YKL-40 (also termed chitinase 3-like 1) inhibit oxidant-induced lung injury, augments adaptive Th2 immunity, regulates apoptosis, stimulates alternative macrophage activation, and contributes to fibrosis and wound healing. In accord with these findings, levels of YKL-40 in the lung and serum are increased in asthma and other inflammatory and remodeling disorders and often correlate with disease severity. Our understanding of the roles of C/CLPs in inflammation, tissue remodeling, and tissue injury in health and disease is reviewed below.
引用
收藏
页码:479 / 501
页数:23
相关论文
共 154 条
  • [61] Serum YKL-40 is increased in patients with hepatic fibrosis
    Johansen, JS
    Christoffersen, P
    Moller, S
    Price, PA
    Henriksen, JH
    Garbarsch, C
    Bendtsen, F
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 (06) : 911 - 920
  • [62] Serum YKL-40, a new prognostic biomarker in cancer patients?
    Johansen, JS
    Jensen, BV
    Roslind, A
    Nielsen, D
    Price, PA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) : 194 - 202
  • [63] Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity?
    Johansen, JS
    Milman, N
    Hansen, M
    Garbarsch, C
    Price, PA
    Graudal, N
    [J]. RESPIRATORY MEDICINE, 2005, 99 (04) : 396 - 402
  • [64] Plasma YKL-40: A new potential marker of fibrosis in patients with alcoholic cirrhosis?
    Johansen, JS
    Moller, S
    Price, PA
    Bendtsen, F
    Junge, J
    Garbarsch, C
    Henriksen, JH
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (06) : 582 - 590
  • [65] Johansen JS, 1999, ARTHRITIS RHEUM-US, V42, P2624, DOI 10.1002/1529-0131(199912)42:12<2624::AID-ANR17>3.0.CO
  • [66] 2-K
  • [67] JOHANSEN JS, 1992, J BONE MINER RES, V7, P501
  • [68] Johansen JS, 2006, DAN MED BULL, V53, P172
  • [69] Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer
    Junker, N
    Johansen, JS
    Andersen, CB
    Kristjansen, PEG
    [J]. LUNG CANCER, 2005, 48 (02) : 223 - 231
  • [70] Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells
    Junker, N
    Johansen, JS
    Hansen, LT
    Lund, EL
    Kristjansen, PEG
    [J]. CANCER SCIENCE, 2005, 96 (03): : 183 - 190